396 related articles for article (PubMed ID: 21865366)
41. Timing of levothyroxine administration affects serum thyrotropin concentration.
Bach-Huynh TG; Nayak B; Loh J; Soldin S; Jonklaas J
J Clin Endocrinol Metab; 2009 Oct; 94(10):3905-12. PubMed ID: 19584184
[TBL] [Abstract][Full Text] [Related]
42. Risks and safety of combination therapy for hypothyroidism.
Jonklaas J
Expert Rev Clin Pharmacol; 2016 Aug; 9(8):1057-67. PubMed ID: 27137849
[TBL] [Abstract][Full Text] [Related]
43. Design of the Optimal Trial of Combination Therapy.
Cappola AR
Front Endocrinol (Lausanne); 2020; 11():168. PubMed ID: 32318021
[TBL] [Abstract][Full Text] [Related]
44. Effects of Altering Levothyroxine Dose on Energy Expenditure and Body Composition in Subjects Treated With LT4.
Samuels MH; Kolobova I; Niederhausen M; Purnell JQ; Schuff KG
J Clin Endocrinol Metab; 2018 Nov; 103(11):4163-4175. PubMed ID: 30165520
[TBL] [Abstract][Full Text] [Related]
45. Does combination T4 and T3 therapy make sense?
McDermott MT
Endocr Pract; 2012; 18(5):750-7. PubMed ID: 22548953
[TBL] [Abstract][Full Text] [Related]
46. Persistent pituitary resistance to thyroid hormone in congenital versus later-onset hypothyroidism.
Cavaliere H; Medeiros-Neto GA; Rosner W; Kourides IA
J Endocrinol Invest; 1985 Dec; 8(6):527-32. PubMed ID: 3938790
[TBL] [Abstract][Full Text] [Related]
47. Extensions, validation, and clinical applications of a feedback control system simulator of the hypothalamo-pituitary-thyroid axis.
Eisenberg M; Samuels M; DiStefano JJ
Thyroid; 2008 Oct; 18(10):1071-85. PubMed ID: 18844475
[TBL] [Abstract][Full Text] [Related]
48. Serum lipid levels in relation to serum thyroid-stimulating hormone and the effect of thyroxine treatment on serum lipid levels in subjects with subclinical hypothyroidism: the Tromsø Study.
Iqbal A; Jorde R; Figenschau Y
J Intern Med; 2006 Jul; 260(1):53-61. PubMed ID: 16789979
[TBL] [Abstract][Full Text] [Related]
49. Effects of Long-Term Combination LT4 and LT3 Therapy for Improving Hypothyroidism and Overall Quality of Life.
Tariq A; Wert Y; Cheriyath P; Joshi R
South Med J; 2018 Jun; 111(6):363-369. PubMed ID: 29863229
[TBL] [Abstract][Full Text] [Related]
50. Spectrum of subclinical and overt hypothyroidism: effect on thyrotropin, prolactin, and thyroid reserve, and metabolic impact on peripheral target tissues.
Staub JJ; Althaus BU; Engler H; Ryff AS; Trabucco P; Marquardt K; Burckhardt D; Girard J; Weintraub BD
Am J Med; 1992 Jun; 92(6):631-42. PubMed ID: 1605145
[TBL] [Abstract][Full Text] [Related]
51. Use of liothyronine (T3) in hypothyroidism: Joint British Thyroid Association/Society for endocrinology consensus statement.
Ahluwalia R; Baldeweg SE; Boelaert K; Chatterjee K; Dayan C; Okosieme O; Priestley J; Taylor P; Vaidya B; Zammitt N; Pearce SH
Clin Endocrinol (Oxf); 2023 Aug; 99(2):206-216. PubMed ID: 37272400
[TBL] [Abstract][Full Text] [Related]
52. Decreased sensitivity of thyrotropin-thyroid hormone feedback control in hypothyroid and athyreotic patients treated with levothyroxine. Is serum triiodothyronine involved?
Solter D; Solter M
Ann Endocrinol (Paris); 2018 Apr; 79(2):62-66. PubMed ID: 29530271
[TBL] [Abstract][Full Text] [Related]
53. Combined therapy with L-thyroxine and L-triiodothyronine compared to L-thyroxine alone in the treatment of primary hypothyroidism.
Fadeyev VV; Morgunova TB; Melnichenko GA; Dedov II
Hormones (Athens); 2010; 9(3):245-52. PubMed ID: 20688622
[TBL] [Abstract][Full Text] [Related]
54. Serum microRNA profiles in athyroid patients on and off levothyroxine therapy.
Massolt ET; Chaker L; Visser TJ; Gillis AJM; Dorssers LCJ; Beukhof CM; Kam BLR; Franssen GJ; Brigante G; van Ginhoven TM; Visser WE; Looijenga LHJ; Peeters RP
PLoS One; 2018; 13(4):e0194259. PubMed ID: 29649216
[TBL] [Abstract][Full Text] [Related]
55. Effect of Levothyroxine Therapy on the Development of Depressive Symptoms in Older Adults With Subclinical Hypothyroidism: An Ancillary Study of a Randomized Clinical Trial.
Wildisen L; Feller M; Del Giovane C; Moutzouri E; Du Puy RS; Mooijaart SP; Collet TH; Poortvliet RKE; Kearney P; Quinn TJ; Klöppel S; Bauer DC; Peeters RP; Westendorp R; Aujesky D; Gussekloo J; Rodondi N
JAMA Netw Open; 2021 Feb; 4(2):e2036645. PubMed ID: 33566107
[TBL] [Abstract][Full Text] [Related]
56. Therapy of primary hypothyroidism with L-triiodothyronine: discordant cardiac and pituitary responses.
Ridgway EC; Cooper DS; Walker H; Daniels GH; Chin WW; Myers G; Maloof F
Clin Endocrinol (Oxf); 1980 Nov; 13(5):479-88. PubMed ID: 7226568
[TBL] [Abstract][Full Text] [Related]
57. Does a combination regimen of thyroxine (T4) and 3,5,3'-triiodothyronine improve depressive symptoms better than T4 alone in patients with hypothyroidism? Results of a double-blind, randomized, controlled trial.
Sawka AM; Gerstein HC; Marriott MJ; MacQueen GM; Joffe RT
J Clin Endocrinol Metab; 2003 Oct; 88(10):4551-5. PubMed ID: 14557420
[TBL] [Abstract][Full Text] [Related]
58. The different requirement of L-T4 therapy in congenital athyreosis compared with adult-acquired hypothyroidism suggests a persisting thyroid hormone resistance at the hypothalamic-pituitary level.
Bagattini B; Cosmo CD; Montanelli L; Piaggi P; Ciampi M; Agretti P; Marco GD; Vitti P; Tonacchera M
Eur J Endocrinol; 2014 Nov; 171(5):615-21. PubMed ID: 25305309
[TBL] [Abstract][Full Text] [Related]
59. [Combination therapy of thyroxine and triiodothyronine in hypothyroid patients].
Nygaard B; Røder ME; Karmisholt J; Kristensen JK
Ugeskr Laeger; 2018 May; 180(19):. PubMed ID: 29761770
[TBL] [Abstract][Full Text] [Related]
60. Randomized double-blind placebo-controlled trial on levothyroxine and liothyronine combination therapy in totally thyroidectomized subjects: the LEVOLIO study.
Brigante G; Santi D; Boselli G; Margiotta G; Corleto R; Monzani ML; Craparo A; Locaso M; Sperduti S; Roy N; Casarini L; Trenti T; Tagliavini S; De Santis MC; Roli L; Rochira V; Simoni M
Eur J Endocrinol; 2024 Jan; 190(1):12-22. PubMed ID: 38124252
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
